secwatch / observer
8-K/A filed August 22, 2023, 7:59 PM ET CIK 0001261249
leadership confidence high sentiment neutral materiality 0.55

Agile Therapeutics appoints Scott Coiante as CFO; discloses employment terms and CAO departure

AGILE THERAPEUTICS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jason Butch

Chief Accounting Officer
AGILE THERAPEUTICS INC
Effective
2023-08-15
Filed
August 22, 2023, 7:59 PM ET
the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch separated from service as the Chief Accounting Officer of the Company, effective August 15, 2023
Appointed

Scott Coiante

Senior Vice President, Chief Financial Officer and Treasurer
AGILE THERAPEUTICS INC
Effective
2023-08-16
Filed
August 22, 2023, 7:59 PM ET
appointed Scott Coiante to serve as the Company’s Senior Vice President, Chief Financial Officer and Treasurer, effective August 16, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Butch departed as Chief Accounting Officer at AGILE THERAPEUTICS INC.

Action
separated
Role
Chief Accounting Officer
Exact text from the filing
the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch separated from service as the Chief Accounting Officer of the Company, effective August 15, 2023
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Coiante was appointed as Senior Vice President, Chief Financial Officer and Treasurer at AGILE THERAPEUTICS INC.

Action
appointed
Role
Senior Vice President, Chief Financial Officer and Treasurer
Exact text from the filing
appointed Scott Coiante to serve as the Company’s Senior Vice President, Chief Financial Officer and Treasurer, effective August 16, 2023
View on SEC.gov
Source: SEC EDGAR
accession 0001558370-23-015153
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.